
1. biochem biophys res commun. 2009 mar 13;380(3):454-9. doi:
10.1016/j.bbrc.2009.01.083. epub 2009 jan 25.

plasmodium falciparum signal peptide peptidase promising drug target against
blood stage malaria.

li x(1), chen h, bahamontes-rosa n, kun jf, traore b, crompton pd, chishti ah.

author information: 
(1)department pharmacology, university illinois college medicine, 909
south wolcott avenue, uic cancer center, mc-704 room 5100, chicago, il 60612,
usa.

the resistance malaria parasites current anti-malarial drugs issue of
major concern globally. recently identified plasmodium falciparum cell
membrane aspartyl protease, binds erythrocyte band 3, involved in
merozoite invasion. report complete primary structure p.
falciparum signal peptide peptidase (pfspp), demonstrate essential
for parasite invasion growth human erythrocytes. gene silencing suggests
that pfspp may essential parasite survival human erythrocytes.
remarkably, mammalian signal peptide peptidase inhibitors (z-ll)(2)-ketone and
l-685,458 effectively inhibited malaria parasite invasion well growth in
human erythrocytes. contrast, dapt, inhibitor related
gamma-secretase/presenilin-1, ineffective. thus, spp inhibitors specific 
pfspp may function potent anti-malarial drugs blood stage malaria.

doi: 10.1016/j.bbrc.2009.01.083 
pmcid: pmc3959855
pmid: 19174148  [indexed medline]

